Investing.com - H.C. Wainwright raised its price target on Axsome Therapeutics (NASDAQ:AXSM) to $200.00 from $185.00 on Monday, while maintaining a Buy rating on the stock. The company’s shares have ...
Many young doctors avoid psychiatry due to social stigma and family expectations. Cultural myths and fears over marriage prospects discourage especially female students. Meanwhile, suicide and mental ...
Michigan State basketball coach Tom Izzo has put on a recruiting masterclass during the 2026 recruiting class, and his run might not be over yet. After securing commitments from Jasiah Jervis, Julius ...
VIRGINIA BEACH, Va. — Virginia Beach EMS implemented a new policy limiting the use of lights and sirens on Priority 2 calls. Chief Jason Stroud said the change, implemented in late October, aligns ...
The paper addresses the challenge of scheduling multiple output priority queues of a switch in a real-world setting characterized by bursty traffic and diverse traffic priorities. Existing queue ...
VIRGINIA BEACH, Va. — This week, an operational change went into effect for Virginia Beach EMS in which first responders will limit the utilization of lights and sirens for calls under their Priority ...
Kate Farmer ably reports that “The Navy at 250 Faces New Challenges” (op-ed, Oct. 13). Secretary John Phelan told our colleagues in the House this summer that our programs are “a mess,” “behind ...
In August, an exclusive Laval golf club took the unusual step of urging members to prioritize the use of French among themselves on the course and in the clubhouse, suggesting that too much English ...
Investors considering a purchase of Array Technologies Inc (Symbol: ARRY) stock, but tentative about paying the going market price of $7.12/share, might benefit from considering selling puts among the ...
The Athletic has live coverage of the 2025 NBA free agency. The NBA Draft was another opportunity for the LA Clippers to utilize their new home, the Intuit Dome, in unforeseen ways. This time a year ...
It is well established that “a petitioner in an inter partes review … is not permitted to assert a ground of unpatentability under 35 U.S.C. § 112.” Dexcowin Golabl, Inc. v. Aribex, Inc., ...